Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

USP launches supplement IVP

This article was originally published in The Tan Sheet

Executive Summary

Argentinean ingredient producer Inter Farma is the first participant in USP's new Ingredient Verification Program for substances used in the manufacture of dietary supplements, the standard-setting organization announced March 31; the firm submitted chondroitin sulfate materials for verification. The organization's IVP process involves evaluation of quality systems and GMP compliance, quality control document review and lab evaluation of ingredient samples. Ingredients granted a USP-IVP verification mark also receive post-verification surveillance testing. USP and industry have urged FDA to allow the use of certificates of analysis in place of extensive batch-testing in supplement GMPs (1"The Tan Sheet" Sept. 1, 2003, p. 7)...

You may also be interested in...



Supplement GMPs Should Set Dissolution, Disintegration Requirements – USP

Dissolution or disintegration requirements for dietary supplements ought to be mandated by FDA in order to confirm product quality, the U.S. Pharmacopeia says in Aug. 11 comments on the supplement good manufacturing practices proposed rule

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.

Metsera Launches As New Obesity Contender Flush With $290m

Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture. 

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096674

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel